0001127602-16-045498.txt : 20160308
0001127602-16-045498.hdr.sgml : 20160308
20160308161842
ACCESSION NUMBER: 0001127602-16-045498
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160307
FILED AS OF DATE: 20160308
DATE AS OF CHANGE: 20160308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SENSIENT TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000310142
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 390561070
STATE OF INCORPORATION: WI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 EAST WISCONSIN AVENUE
CITY: MILWAUKEE
STATE: WI
ZIP: 53202
BUSINESS PHONE: 4142716755
MAIL ADDRESS:
STREET 1: PO BOX 737
CITY: MILWAUKEE
STATE: WI
ZIP: 53201
FORMER COMPANY:
FORMER CONFORMED NAME: UNIVERSAL FOODS CORP
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEDRAL ELAINE R
CENTRAL INDEX KEY: 0001267533
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07626
FILM NUMBER: 161491789
MAIL ADDRESS:
STREET 1: C/O BALCHEM CORP
STREET 2: P O BOX 600
CITY: NEW HAMPTON
STATE: NY
ZIP: 10958
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2016-03-07
0000310142
SENSIENT TECHNOLOGIES CORP
SXT
0001267533
WEDRAL ELAINE R
777 EAST WISCONSIN AVENUE
MILWAUKEE
WI
53202
1
Common Stock
2016-03-07
4
M
0
2000
20.25
A
16923.212
D
Stock Options (Right to Buy)
20.25
2016-03-07
4
M
0
2000
0
D
2007-05-01
2016-05-01
Common Stock
2000
0
D
Stock Options (Right to Buy)
26.12
2008-05-01
2017-05-01
Common Stock
2000
2000
D
Stock Options (Right to Buy)
30.07
2009-05-01
2018-05-01
Common Stock
2000
2000
D
Exercise of in-the-money stock option that would otherwise expire on 5/1/2016, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan.
Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.
/s/ John L. Hammond, Attorney-in-Fact for Dr. Wedral
2016-03-08